Preclinical activity of LM-305 targeting G-protein-coupled receptor class 5 member D (GPRC5D) antibody drug conjugate for the treatment of multiple myeloma

被引：0
|
作者：
Huang, Wentao [1 ]
Luo, Jie [1 ]
Li, Yifan [1 ]
Fei, Da [1 ]
Qin, Xia [1 ]
Li, Runsheng [1 ]
机构：
[1] LaNova Med, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6020
引用
收藏
页数：1
相关论文
共 44 条
  • [31] FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma
    Reiser, John
    Chan, Szeman Ruby
    Mathavan, Ketan
    Sillitti, David
    Mottershead, Cristina
    Mattson, Bethany
    Pache, Melissandre
    Gutierrez, Alma
    Scoon, Whitney
    Zhu, Yanni
    Gilder, Andrew
    Chen, Christine
    Staquet, Kimberly
    Ports, Michael
    Drake, Charles
    Erhardt, Joseph
    Bjordahl, Ryan
    Goodridge, Jode P.
    Valamehr, Bahram
    BLOOD, 2022, 140 : 4560 - 4561
  • [32] Dermatological toxicities induced by T-cell-redirecting G protein-coupled receptor family C class 5 member D bispecific antibody talquetamab
    Lery, Marion
    Perrot, Aurore
    Ortiz-Brugues, Ariadna
    Vigarios, Emmanuelle
    Anghel, Diana
    Bories, Pierre
    Sibaud, Vincent
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (02) : 376 - 377
  • [33] A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models
    Urara Tomita
    Yoko Ishimoto
    Masaki Ri
    Yumi Kawase
    Yoshiyuki Hizukuri
    Chikako Maru
    Kayoko Nanai
    Ryuichi Nakamura
    Makiko Nakayama
    Keiko Oguchi-Oshima
    Hiroyuki Sumi
    Toshiaki Ohtsuka
    Shinsuke Iida
    Toshinori Agatsuma
    Scientific Reports, 14
  • [34] Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma
    Atamaniuk, Johanna
    Gleiss, Andreas
    Porpaczy, Edit
    Kainz, Birgit
    Grunt, Thomas W.
    Raderer, Markus
    Hilgarth, Bernadette
    Drach, Johannes
    Ludwig, Heinz
    Gisslinger, Heinz
    Jaeger, Ulrich
    Gaiger, Alexander
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (09) : 953 - 960
  • [35] A novel T cell-redirecting anti-GPRC5D x CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models
    Tomita, Urara
    Ishimoto, Yoko
    Ri, Masaki
    Kawase, Yumi
    Hizukuri, Yoshiyuki
    Maru, Chikako
    Nanai, Kayoko
    Nakamura, Ryuichi
    Nakayama, Makiko
    Oguchi-Oshima, Keiko
    Sumi, Hiroyuki
    Ohtsuka, Toshiaki
    Iida, Shinsuke
    Agatsuma, Toshinori
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [36] Characterization and Management of Oral and Dermatological Toxicities in Patients Receiving the CD3 X GPRC5D Bispecific Antibody Talquetamab (JNJ-64407564) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
    Mancia, Stefania Stefania
    Farrell, Annamaria
    Louw, Karen
    Florendo, Erika
    Aronson, Elizabeth
    Purcell, Kiah
    Catamero, Donna D.
    Escalon, Juliet
    Thomas, Joanne
    Aponte, Annel
    Lamb, Angela
    Kirke, Diana
    Lucas, Aimee
    Jagannath, Sundar
    Cho, Hearn Jay
    Parekh, Samir
    Richter, Joshua
    Sanchez, Larysa
    Chari, Ajai
    BLOOD, 2021, 138
  • [37] Co-Expression of GPRC5D, FcRH5 and BCMA Suggests That Targeting More Than One Cell Surface Marker May be a Viable Strategy in Relapsed/Refractory Multiple Myeloma (RRMM): Biomarker Results from the Phase I Study of Forimtamig, a GPRC5DxCD3 Bispecific Antibody
    Dekhtiarenko, Iryna
    Lelios, Iva
    Jacob, Wolfgang
    Schneider, Meike
    Weisser, Martin
    Carlo-Stella, Carmelo
    Manier, Salomon
    Harrison, Simon J.
    Popat, Rakesh
    Riley, Anna Caroline Hasselbalch
    Broeke, Ann-Marie E.
    BLOOD, 2023, 142
  • [38] Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase II Trial
    Xia, Jieyun
    Li, Hujun
    Yan, Zhiling
    Zhou, Dian
    Wang, Ying
    Qi, Yuekun
    Cao, Jiang
    Li, Depeng
    Cheng, Hai
    Sang, Wei
    Zhu, Feng
    Sun, Haiying
    Chen, Wei
    Qi, Kunming
    Yan, Dongmei
    Qiu, Tingting
    Qiao, Jianlin
    Yao, Ruosi
    Liu, Yang
    Wang, Xue
    Zhang, Yanlei
    Peng, Shuixiu
    Huang, Chih-Hua
    Zheng, Junnian
    Li, Zhenyu
    Chang, Alex H. H.
    Xu, Kailin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2583 - +
  • [39] Talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in relapsed/refractory multiple myeloma: efficacy and safety of patient subgroups from monumenTAL-1
    Krishnan, Amrita
    Costa, Luciano
    Schinke, Carolina
    Karlin, Lionel
    Morillo, Daniel
    Martinez-Chamorro, Carmen
    Ye, Jing Christine
    Chari, Ajai
    Moreau, Philippe
    Caers, Jo
    Jakubowiak, Andrzej
    Campagna, Michela
    Masterson, Tara
    Hilder, Brandi
    Tolbert, Jaszianne
    Renaud, Thomas
    Smit, M. Damiette
    Heuck, Christoph
    Minnema, Monique
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S45 - S46
  • [40] Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from MonumenTAL-1
    Chari, Ajai
    Touzeau, Cyrille
    Schinke, Carolina
    Minnema, Monique C.
    Berdeja, Jesus
    Oriol, Albert
    Van de Donk, Niels W. C. J.
    Rodriguez Otero, Paula
    Askari, Elham
    Mateos, Maria-Victoria
    Costa, Luciano J.
    Caers, Jo
    Rasche, Leo
    Krishnan, Amrita Y.
    Vishwamitra, Deeksha
    Ma, Xuewen
    Qin, Xiang
    Gries, Katharine S.
    Campagna, Michela
    Masterson, Tara
    Hilder, Brandi
    Tolbert, Jaszianne
    Renaud, Thomas
    Goldberg, Jenna D.
    Heuck, Christoph
    San-Miguel, Jesus
    Moreau, Philippe
    BLOOD, 2022, 140
12345